266 related articles for article (PubMed ID: 21376634)
1. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
Elahi MM; Lam J; Asopa S; Matata BM
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
[No Abstract] [Full Text] [Related]
2. [Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
García-González MJ; Domínguez-Rodríguez A
Rev Esp Cardiol; 2006 Aug; 59(8):851-2. PubMed ID: 16938238
[No Abstract] [Full Text] [Related]
3. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
4. Perioperative use of levosimendan: best practice in operative settings.
Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687
[No Abstract] [Full Text] [Related]
5. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan for low cardiac output: a pediatric experience.
Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
[TBL] [Abstract][Full Text] [Related]
7. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
[No Abstract] [Full Text] [Related]
8. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
Severi L; Lappa A; Landoni G; Di Pirro L; Luzzi SJ; Caravetta P; Cipullo P; Menichetti A
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):632-6. PubMed ID: 21546269
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
10. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
Laine M; Lehtonen L; Nieminen MS
Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
[No Abstract] [Full Text] [Related]
11. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.
Lomivorotov VV; Boboshko VA; Efremov SM; Kornilov IA; Chernyavskiy AM; Lomivorotov VN; Knazkova LG; Karaskov AM
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):596-603. PubMed ID: 22051419
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan in cardiac surgery: current best available evidence.
Raja SG; Rayen BS
Ann Thorac Surg; 2006 Apr; 81(4):1536-46. PubMed ID: 16564321
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.
Papoff P; Caresta E; Versacci P; Pinto R; Moretti C; Midulla F
Pediatr Emerg Care; 2012 Oct; 28(10):1062-5. PubMed ID: 23034494
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.
Zangrillo A; Biondi-Zoccai G; Mizzi A; Bruno G; Bignami E; Gerli C; De Santis V; Tritapepe L; Landoni G
J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):474-8. PubMed ID: 19217315
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
[TBL] [Abstract][Full Text] [Related]
19. Medical support and surgery of the failing heart: levosimendan.
Toller W; Knez I
Scand J Surg; 2007; 96(2):121-4. PubMed ID: 17679353
[No Abstract] [Full Text] [Related]
20. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
